Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-19

Clinical Trial Update: Efficacy and Safety of Eslicarbazepine Acetate as Therapy in Subjects With Fibromyalgia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of eslicarbazepine acetate in fibromyalgia; study completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Fibromyalgia | Phase 2 | Status: COMPLETED | Results posted: 2013-07-19